+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Influenza Drug"

From
From
FLU-v Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLU-v Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
H1N1 (Swine Influenza) - Epidemiology Forecast to 2032 - Product Thumbnail Image

H1N1 (Swine Influenza) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Influenza Medication Market Report and Forecast 2023-2031 - Product Thumbnail Image

Influenza Medication Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
Seasonal Influenza: Competitive Landscape to 2026 - Product Thumbnail Image

Seasonal Influenza: Competitive Landscape to 2026

  • Report
  • November 2018
  • 49 Pages
  • Global
From
US Influenza Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Influenza Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Loading Indicator

The Influenza Drug market is a subset of the larger Respiratory Drug market, which includes treatments for a variety of respiratory illnesses, such as asthma, COPD, and cystic fibrosis. Influenza drugs are used to treat the symptoms of the flu, such as fever, cough, and sore throat. These drugs can also help reduce the risk of complications from the flu, such as pneumonia. Commonly used influenza drugs include antivirals, such as oseltamivir and zanamivir, and anti-inflammatory drugs, such as ibuprofen and acetaminophen. Some companies in the Influenza Drug market include GlaxoSmithKline, Sanofi, Novartis, and AstraZeneca. Other companies include Roche, Merck, and Pfizer. Show Less Read more